4523

Eisai Co., Ltd.

エーザイ株式会社
Pharmaceutical
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in India. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
← Companies
Price
¥3,984
Market Cap
¥1.1T
Ent. Value
¥1.0T
Net Cash
¥78.0B
Shares Out.
282.1M
P / E
24.3×
EV / EBIT
19.2×
P / Book
—
P / NCAV
5.43×
Div. Yield
4.02%
Financials
Metric FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗ 		FY 2021
EDINET ↗
Net Sales ¥789.4B ¥741.8B ¥744.4B ¥756.2B
Cost of Sales ¥168.8B ¥155.3B ¥177.8B ¥174.8B
Gross Profit ¥620.6B ¥586.4B ¥566.6B ¥581.4B
SG&A ¥408.0B ¥374.4B ¥358.3B ¥366.4B
Operating Income ¥54.4B ¥53.4B ¥40.0B ¥53.8B
Non-Operating Income ¥10.2B ¥10.8B ¥7.2B ¥2.4B
Non-Operating Expenses ¥3.5B ¥2.4B ¥2.3B ¥1.7B
Pre-tax Income ¥61.1B ¥61.8B ¥45.0B ¥54.5B
Net Income (owners) ¥46.4B ¥42.4B ¥55.4B ¥48.0B
Minority Interest ¥1.6B ¥1.4B ¥1.4B ¥-2.2B
Comprehensive Income ¥43.2B ¥122.8B ¥96.9B ¥90.8B
EBITDA ¥94.3B ¥92.8B ¥80.0B ¥92.1B
EPS ¥163.76 ¥147.86 ¥193.31 ¥167.27
Shares Outstanding 282.1M 287.0M 286.9M 286.8M
Shares Issued (total) 291.6M 296.6M 296.6M 296.6M
Treasury Shares 9.5M 9.5M 9.7M 9.8M